Kezar Life Sciences to Present During Upcoming Virtual Investor Conferences

SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced members of the executive team will present during upcoming virtual investor conferences. The details of the presentations are as follows: Jefferies Virtual London Healthcare Conference Wednesday, November 18, 2020, 1:10pm EST (Fireside Chat) Presenters: John Fowler, Ch

Click to view original post